Implications of hepatitis C viremia vs. antibody alone on transmission among male injecting drug users in three Afghan cities

scientific article

Implications of hepatitis C viremia vs. antibody alone on transmission among male injecting drug users in three Afghan cities is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.IJID.2010.11.006
P932PMC publication ID7153690
P698PubMed publication ID21190883
P5875ResearchGate publication ID49714220

P50authorSteffanie StrathdeeQ7606605
Jerome H KimQ56871312
Catherine S ToddQ90482896
Christian T. BautistaQ39749039
P2093author name stringPaul T Scott
Boulos A Botros
Jeffrey Tjaden
Abdul Nasir
Mohammad R Stanekzai
P2860cites workHepatitis C virus reinfection in injection drug usersQ43032645
Prevalence and correlates of hepatitis C virus infection among injecting drug users in TehranQ45400111
Prevalence of Infections, HIV Risk Behaviors and Factors Associated with HIV Infection Among Male Injecting Drug Users Attending a Needle/Syringe Exchange Program in Dhaka, BangladeshQ57928455
High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in PakistanQ24673331
Hepatitis C virus infection in san francisco’s HIV-infected urban poorQ27473306
Correlates of spontaneous clearance of hepatitis C virus among people with hemophiliaQ27480307
Global epidemiology of hepatitis C virus infectionQ27860799
HIV, hepatitis C, and hepatitis B infections and associated risk behavior in injection drug users, Kabul, AfghanistanQ33800854
Acute hepatitis C.Q34013032
Protection against persistence of hepatitis C.Q34126534
Factors associated with hepatitis C viremia in a large cohort of HIV-infected and -uninfected womenQ36384812
HIV in prison in low-income and middle-income countriesQ36689479
HIV, hepatitis B, and hepatitis C prevalence and associated risk behaviors among female sex workers in three Afghan citiesQ36833659
High prevalence of HIV, HIV/hepatitis C virus coinfection, and risk behaviors among injection drug users in Chennai, India: a cause for concernQ37349751
Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemicQ37421029
HIV among injecting drug users: current epidemiology, biologic markers, respondent-driven sampling, and supervised-injection facilitiesQ37521729
Genetic epidemiology of hepatitis C virus throughout egyptQ39387214
High incidence of hepatitis C virus reinfection within a cohort of injecting drug usersQ39797179
High incidence of hepatitis C virus reinfection in a cohort of injecting drug usersQ40037737
Correlates of hepatitis C virus infections among injection drug users.Q40453200
Drug injecting and syringe use in the HIV risk environment of Russian penitentiary institutions: Qualitative studyQ42605594
Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in IndiaQ42607025
Tracking the entry routes of hepatitis C virus as a surrogate of HIV in an HIV-low prevalence country, the PhilippinesQ42622609
High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China.Q42669522
High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infectionQ42985356
Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapyQ42993106
Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion.Q42994569
Predictors of hepatitis C virus RNA levels in a prospective cohort study of drug usersQ42999935
Multicenter evaluation of hepatitis C RNA levels among female injection drug usersQ43030214
P433issue3
P304page(s)e201-5
P577publication date2010-12-28
P1433published inInternational Journal of Infectious DiseasesQ15262334
P1476titleImplications of hepatitis C viremia vs. antibody alone on transmission among male injecting drug users in three Afghan cities
P478volume15

Reverse relations

cites work (P2860)
Q27000368Burden of Gastrointestinal and Liver Diseases in Middle East and North Africa: Results of Global Burden of Diseases Study from 1990 to 2010
Q42278804Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan
Q39041105Is rapid hepatitis C virus testing from corpses a screening option for index persons who have died after mass-casualty incidents in high-prevalence settings in the field?
Q42720607Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs
Q28389933Share of Afghanistan populace in hepatitis B and hepatitis C infection's pool: is it worthwhile?
Q26784519The epidemiology of hepatitis C virus in Afghanistan: systematic review and meta-analysis

Search more.